Patient-Reported Symptoms Over 48 Weeks in a Randomized, Open-Label, Phase IIIb Non-Inferiority Trial of Adults with HIV Switching to Co-Formulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir DF versus Continuation of Non-Nucleoside Rever
about
Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project.Patient-Reported Symptoms over 48 Weeks in a Randomized, Open-Label, Phase 3b Non-inferiority Trial of Adults with HIV Switching to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir DF Versus Continuation of Ritonavir-Boosted ProteSwitching regimens in virologically suppressed HIV-1-infected patients: evidence base and rationale for integrase strand transfer inhibitor (INSTI)-containing regimens.Elvitegravir for the treatment of HIV.Switching to the single-tablet regimen of elvitegravir, cobicistat, emtricitabine, and tenofovir DF from non-nucleoside reverse transcriptase inhibitor plus coformulated emtricitabine and tenofovir DF regimens: Week 96 results of STRATEGY-NNRTI.Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in Asian Subjects with Human Immunodeficiency Virus 1 Infection: A Sub-Analysis of Phase 3 Clinical Trials.
P2860
Patient-Reported Symptoms Over 48 Weeks in a Randomized, Open-Label, Phase IIIb Non-Inferiority Trial of Adults with HIV Switching to Co-Formulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir DF versus Continuation of Non-Nucleoside Rever
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Patient-Reported Symptoms Over ...... uation of Non-Nucleoside Rever
@ast
Patient-Reported Symptoms Over ...... uation of Non-Nucleoside Rever
@en
type
label
Patient-Reported Symptoms Over ...... uation of Non-Nucleoside Rever
@ast
Patient-Reported Symptoms Over ...... uation of Non-Nucleoside Rever
@en
prefLabel
Patient-Reported Symptoms Over ...... uation of Non-Nucleoside Rever
@ast
Patient-Reported Symptoms Over ...... uation of Non-Nucleoside Rever
@en
P2093
P2860
P1476
Patient-Reported Symptoms Over ...... uation of Non-Nucleoside Rever
@en
P2093
Anthony Mills
Anton Pozniak
Juan Berenguer
Randall Bender
Rebecca M Speck
Thai Nguyen
Will Garner
P2860
P2888
P304
P356
10.1007/S40271-015-0129-9
P577
2015-06-05T00:00:00Z